GL1X · GenesisL1 explorer

MolNFT v1 · #15072 · protein

Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy

1MT8 · Protease retropepsin: “Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy”. X-ray diffraction, 1 pocket (best druggability 0.39). MolNFT v1 #15072 on GenesisL1: 3D structure…

PDB
1MT8
Type
protein
Length
206 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease retropepsin; Capsid-P2 substrate peptide of HIV-1 gag polyprotein
EC
3.4.23.16
UniProt
P03369, Q9YX54
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 4% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease retropepsin (EC 3.4.23.16)protein994% helix, 55% strandP03369
PCapsid-P2 substrate peptide of HIV-1 gag polyproteinprotein80% helix, 50% strandQ9YX54

Ligands and binding sites

  • ACT · Acetate ion · additive · 3 copies · chains B, A, P

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1730.390.7817empty

Interfaces

3 interfaces between chains.

  • A–B · 1842 Ų buried · 36 hydrogen bonds · protein-protein
  • B–P · 511 Ų buried · 10 hydrogen bonds · protein-protein
  • A–P · 454 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 1MT8 · Viability of a drug-resistant HIV-1 protease mutant: structural insights for better… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.